Veru (VERU) News Today $0.53 +0.02 (+3.85%) Closing price 05/28/2025 04:00 PM EasternExtended Trading$0.51 -0.02 (-3.33%) As of 07:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Muscle-sparing obesity drug safe for Phase 3 trial, Veru saysMay 28 at 11:32 PM | yahoo.comVeru Inc. Announce Positive Topline Safety Data from Phase 2b QUALITY Study of Enobosarm Combined with SemaglutideMay 28 at 6:55 AM | quiverquant.comVeru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide AloneMay 28 at 6:30 AM | globenewswire.comVeru: Saving Muscle Mass Amidst The GLP-1 Drug BoomMay 26 at 10:01 PM | seekingalpha.comYoungsters at Dunstable school hear about the dangers of knife crimeMay 22, 2025 | msn.comB. Riley Analysts Decrease Earnings Estimates for VeruVeru Inc. (NASDAQ:VERU - Free Report) - Analysts at B. Riley lowered their Q4 2025 EPS estimates for shares of Veru in a research note issued on Wednesday, May 14th. B. Riley analyst W. Wood now expects that the company will earn ($0.06) per share for the quarter, down from their prior estimate oMay 21, 2025 | marketbeat.com4,285,365 Shares in Veru Inc. (NASDAQ:VERU) Acquired by MPM Bioimpact LLCMPM Bioimpact LLC purchased a new stake in Veru Inc. (NASDAQ:VERU - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 4,285,365 shares of the company's stock, valued at approximately $2,788,000. MPM BioimpMay 16, 2025 | marketbeat.comVeru (NASDAQ:VERU) Posts Earnings Results, Beats Expectations By $0.01 EPSVeru (NASDAQ:VERU - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01. Veru had a negative net margin of 223.85% and a negative return on equity of 112.75%.May 12, 2025 | marketbeat.comVeru Inc.: Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program ProgressMay 8, 2025 | finanznachrichten.deVeru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trialMay 8, 2025 | msn.comVeru Inc. (VERU) Q2 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comJTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next LevelMay 8, 2025 | finanznachrichten.deVeru Participates in a Virtual Investor KOL Connect SegmentMay 8, 2025 | globenewswire.comVeru Inc. Announces Upcoming Safety Data and Phase 2b Study Updates for Enobosarm in Weight Management TreatmentMay 8, 2025 | quiverquant.comVeru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program ProgressMay 8, 2025 | globenewswire.comA Peek at Veru's Future EarningsMay 8, 2025 | benzinga.comVeru (VERU) Projected to Post Quarterly Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing its Q2 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-veru-inc-stock/)May 4, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $1.50 Million Stock Holdings in Veru Inc. (NASDAQ:VERU)Adage Capital Partners GP L.L.C. reduced its holdings in shares of Veru Inc. (NASDAQ:VERU - Free Report) by 70.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,300,000 shares of the company's stock after selliMay 2, 2025 | marketbeat.comVeru to Report Fiscal 2025 Second Quarter Financial Results on May 8May 1, 2025 | globenewswire.comVeru to Present at the 2nd Annual GLP-1-Based Therapeutics SummitApril 16, 2025 | globenewswire.comVeru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation ConferenceMarch 31, 2025 | globenewswire.comUnusually active option classes on open March 25thMarch 25, 2025 | markets.businessinsider.comVeru Sees Unusually High Options Volume (NASDAQ:VERU)Veru Inc. (NASDAQ:VERU - Get Free Report) saw unusually large options trading on Monday. Stock investors acquired 9,142 call options on the stock. This is an increase of 206% compared to the typical daily volume of 2,983 call options.March 18, 2025 | marketbeat.comVeru Inc. Shareholders Approve Equity Plan AmendmentMarch 14, 2025 | tipranks.comHere's Why Veru (VERU) Looks Ripe for Bottom FishingMarch 12, 2025 | msn.comVeru Inc. (NASDAQ:VERU) Holdings Raised by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. grew its position in Veru Inc. (NASDAQ:VERU - Free Report) by 181.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,120,586 shares of the company's stock after acquiring an additional 722,644 sharesMarch 6, 2025 | marketbeat.comInsider Buying: Veru Inc. (NASDAQ:VERU) Director Purchases 95,279 Shares of StockVeru Inc. (NASDAQ:VERU - Get Free Report) Director Michael L. Rankowitz bought 95,279 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $0.55 per share, with a total value of $52,403.45. Following the completion of the acquisition, the director now owns 195,279 shares in the company, valued at $107,403.45. This represents a 95.28 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 21, 2025 | marketbeat.comVeru Inc. (NASDAQ:VERU) Director Michael L. Rankowitz Purchases 95,279 SharesFebruary 21, 2025 | insidertrades.comFocus: Next generation weight loss drugs aim to save muscleFebruary 19, 2025 | reuters.comNew weight loss drugs aim to promote muscle growthFebruary 19, 2025 | msn.comVeru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in JanuaryVeru Inc. (NASDAQ:VERU - Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 14,620,000 shares, a growth of 14.3% from the January 15th total of 12,790,000 shares. Based on an average daily volume of 2,950,000 shares, the short-interest ratio is currently 5.0 days.February 16, 2025 | marketbeat.comVeru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call TranscriptFebruary 14, 2025 | msn.comVeru: Discussions on tariffs are negotiation means to an endFebruary 14, 2025 | msn.comVeru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...February 14, 2025 | finance.yahoo.comVeru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatmentFebruary 13, 2025 | msn.comVeru Inc (VERU) Q1 2025 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comVeru (NASDAQ:VERU) Issues Earnings ResultsVeru (NASDAQ:VERU - Get Free Report) released its earnings results on Thursday. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.01. Veru had a negative return on equity of 92.88% and a negative net margin of 223.85%.February 13, 2025 | marketbeat.comVeru Inc.: Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressFebruary 13, 2025 | finanznachrichten.deVeru reports Q1 cont-op EPS (1c) vs. (8c) last yearFebruary 13, 2025 | markets.businessinsider.comEarnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dipsFebruary 13, 2025 | msn.comVeru (NASDAQ:VERU) Announces Quarterly Earnings ResultsVeru (NASDAQ:VERU - Get Free Report) released its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.01. Veru had a negative return on equity of 92.88% and a negative net margin of 223.85%.February 13, 2025 | marketbeat.comVeru Inc. Reports Positive Phase 2b QUALITY Study Results and Announces New Indication for Sabizabulin in Atherosclerotic Coronary Artery DiseaseFebruary 13, 2025 | quiverquant.comVeru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressFebruary 13, 2025 | globenewswire.comADAGE CAPITAL PARTNERS GP, L.L.C. Reduces Stake in Veru Inc.February 12, 2025 | gurufocus.comVeru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | finance.yahoo.comVeru (VERU) Projected to Post Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing earnings before the market opens on Thursday, February 6, Financial Modeling Prep reports.February 4, 2025 | marketbeat.comVeru (VERU) to Release Quarterly Earnings on ThursdayVeru (NASDAQ:VERU) will be releasing earnings before the market opens on Thursday, February 6, Financial Modeling Prep reports.January 30, 2025 | marketbeat.comVeru Inc.’s Promising Phase IIb Results Suggest Investment Opportunity with Enobosarm’s Weight Management PotentialJanuary 28, 2025 | markets.businessinsider.comVeru’s enobosarm meets primary endpoint in Phase 2b weight reduction trialJanuary 27, 2025 | markets.businessinsider.comOppenheimer maintains Veru stock Outperform rating, $5 targetJanuary 27, 2025 | msn.com Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address VERU Media Mentions By Week VERU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERU News Sentiment▼0.390.87▲Average Medical News Sentiment VERU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERU Articles This Week▼62▲VERU Articles Average Week Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NATR News MED News EL News PBH News IPAR News HLF News USNA News NUS News TRDA News IMMP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERU) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VERU Stock Free VERU Stock Alerts